Get App Open
In App
Credit Cards
Open App

Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Dec 09, 16:01
1701.55 164.75 (10.72%)
Volume
AVERAGE VOLUME
5-Day
14,297
10-Day
12,305
30-Day
34,495
194,260
  • Prev. Close

    1536.80

  • Open Price

    1534.05

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 09, 15:59
1701.30 167.40 (10.91%)
Volume
AVERAGE VOLUME
5-Day
249,268
10-Day
212,591
30-Day
244,631
3,842,853
  • Prev. Close

    1533.90

  • Open Price

    1537.90

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1701.30 (393)

Financials

Capital Structure of Eris Lifesciences
Period
Instrument Authorized Capital Issued Capital - P A I D U P -
FromTo   (Rs. cr) (Rs. cr) Shares (nos) Face Value Capital
20242025 Equity Share 30 13.62 136,162,569 1 13.62
20232024 Equity Share 30 13.60 136,028,280 1 13.60
20222023 Equity Share 30 13.60 135,992,238 1 13.60
20212022 Equity Share 30 13.59 135,930,197 1 13.59
20202021 Equity Share 30 13.58 135,780,653 1 13.58
20192020 Equity Share 30 13.58 135,780,653 1 13.58
20182019 Equity Share 30 13.75 137,519,783 1 13.75
20172018 Equity Share 30 13.75 137,500,000 1 13.75
20162017 Equity Share 30 13.75 137,500,000 1 13.75
20152016 Equity Share 10 0.14 137,500 10 0.14
Source : Dion Global Solutions Limited
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347